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Abstract
Staphylococcus aureus is a dangerous human pathogen. A number of the proteins secreted by this bacterium are
implicated in its virulence, but many of the components of its secretome are poorly characterized. Strains of S.
aureus can produce up to six homologous extracellular serine proteases grouped in a single spl operon. Although the
SplA, SplB, and SplC proteases have been thoroughly characterized, the properties of the other three enzymes have
not yet been investigated. Here, we describe the biochemical and structural characteristics of the SplD protease. The
active enzyme was produced in an Escherichia coli recombinant system and purified to homogeneity. P1 substrate
specificity was determined using a combinatorial library of synthetic peptide substrates showing exclusive preference
for threonine, serine, leucine, isoleucine, alanine, and valine. To further determine the specificity of SplD, we used
high-throughput synthetic peptide and cell surface protein display methods. The results not only confirmed SplD
preference for a P1 residue, but also provided insight into the specificity of individual primed- and non-primed
substrate-binding subsites. The analyses revealed a surprisingly narrow specificity of the protease, which recognized
five consecutive residues (P4-P3-P2-P1-P1’) with a consensus motif of R-(Y/W)-(P/L)-(T/L/I/V)↓S. To understand the
molecular basis of the strict substrate specificity, we crystallized the enzyme in two different conditions, and refined
the structures at resolutions of 1.56 Å and 2.1 Å. Molecular modeling and mutagenesis studies allowed us to define a
consensus model of substrate binding, and illustrated the molecular mechanism of protease specificity.
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Introduction
Staphylococcus aureus is a highly prevalent commensal
bacterium that transiently or persistently colonizes the nares of
30%–70% of the human population without any detectable
adverse effects [1]. However, S. aureus is also one of the
major human pathogens, being responsible for a broad
spectrum of diseases [2]. Staphylococcal infections range from
common and relatively harmless ailments such as minor skin
infections (boils, abscesses, folliculitis, impetigo) and food
poisoning, to life-threatening conditions such as toxic epidermal
necrolysis, toxic shock syndrome, osteomyelitis, endocarditis,
meningitis, pneumonia, and sepsis [3]. The overall incidence of
infections caused only by methicillin-resistant S. aureus
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(MRSA) was reported to be 31.8 cases per 100,000 people per
year and the associated mortality rate was 6.3 per 100,000 [4].
The alarming increase in antibiotic resistance observed in
hospitals and in community settings in recent years has
prompted many studies focusing on staphylococcal physiology
[5,6].
The environmental success of S. aureus depends on the
ability to produce redundant virulence factors, particularly
secretory proteases. The proteases, as a group, are of great
importance to the virulence of the bacterium [7,8].
Staphylococci are able to secrete up to eight different serine
proteases, two cysteine proteases, and one metalloprotease.
Individual proteases have diverging roles in the infection
process, including inactivation of the host’s protease inhibitors
and antimicrobial peptides, modulation of kinin and chemokine
synthesis, degradation of immunoglobulins and complement
cascade proteins, modification of the bacterial surface,
interactions with components of the coagulation and fibrinolysis
pathways, and other [9,10,11,12,13,14,15]. However, the
specific contributions of the staphylococcal proteolytic system
and its individual proteases, except for epidermolytic toxins, to
the pathogenicity of S. aureus in vivo are still far from being
fully understood.
Staphylococcal serine proteases encoded in the spl operon
are the least characterized of all of the secreted proteolytic
enzymes. The operon is located on a pathogenicity island,
vSaβ and is adjacent to the genes encoding the enterotoxins
and leukocidins, the well-characterized virulence factors [16].
Analysis of 167 clinical isolates of S. aureus demonstrated that
the complete spl operon (containing all 6 Spl protease
encoding genes, splA–F) is present in the genomes of 31% of
isolates. Additionally, 53% of isolates contained incomplete
operons encoding 1–5 different Spl proteases. The other 36%
of strains had no genes encoding Spl proteases [17]. Like other
virulence factors, the spl operon is transcribed during the early
stationary growth phase, and its expression is regulated by the
global accessory gene regulator (agr) [18,19]. The first Spl
protease (SplC) was identified in 1997 by high-throughput
screening of proteins that cross-reacted with serum from a
patient with endocarditis [20]. To date, SplA, SplB, and SplC
are the best-characterized Spl proteases in terms of their
biochemical and structural properties [21,22,23]. These three
enzymes show significant structural homology to V8 protease
and epidermolytic toxins, the important virulence factors of S.
aureus. Except for SplC, for which proteolytic activity has not
yet been convincingly demonstrated, SplA and SplB exhibit
very limited substrate specificity. So far, the properties of SplD,
SplE, and SplF have not been published.
In the present study, we describe the production of active
recombinant SplD protease, and its enzymatic and structural
properties. We demonstrate its strict substrate specificity using
complementary, high-throughput screening methods. The
molecular basis of its strict substrate preference is explained
using X-ray crystallography, molecular modeling and
mutagenesis studies. Finally, we discuss the possible
physiological role of SplD in the context of future investigations.
Materials and Methods
Expression and purification of SplD protease, its
mutants and the protein substrate
A fragment of the splD gene encoding the mature protease
without the secretion signal peptide was amplified by PCR from
genomic DNA of S. aureus strain 8325-4, and was cloned into
pGEX-5T [24] vector. Ser156Ala, Tyr172Ala and Pro177Gly
mutants were obtained by site directed mutagenesis using the
template of thrombin cleavable construct. The proteins were
expressed in E. coli strain BL21(DE3)pLysS (Invitrogen) in
Luria-Bertani (LB) broth containing chloramphenicol (34 μg/ml)
and ampicillin (100 μg/ml). The cells were cultured at 37 °C
until the optical density at 600 nm (OD600) reached 0.8 and then
at room temperature until the OD600 reached 1.2. Protein
expression was induced by 1 mM isopropyl β-D-1-
thiogalactopyranosid, and culture maintained for another 4 h at
room temperature. Bacteria were collected by centrifugation,
resuspended in phosphate-buffered saline, and sonicated. The
glutathione S-transferase (GST)-SplD fusion protein was
purified by affinity chromatography on Glutathione Sepharose
(Amersham Biosciences). Four different fusion proteins with
linkers engineered to be specifically cleaved by thrombin,
CleanCut (Sigma), factor Xa, and SplD were evaluated.
Cleavage with thrombin (BioCentrum) was performed on the
affinity column in 50 mM Tris-HCl, pH 8.0. The other fusion
proteins were eluted from the affinity column and then treated
with the relevant protease. All preparations were then dialyzed
against 50 mM sodium acetate, pH 5.0. SplD was recovered by
ion exchange chromatography on SourceS resin (Amersham
Biosciences) followed by gel filtration on Superdex s75pg
(Amersham Biosciences) equilibrated with 5 mM Tris-HCl, 50
mM NaCl, pH 8.0 for crystallization, or with 50 mM Tris-HCl, pH
8.0, for long-term storage at -20 °C. All SplD preparations used
in this study were of >95% purity, as determined by sodium
dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis
(PAGE).
A fusion protein containing GST and catabolite repressor
protein (CRP) was constructed by cloning the crp gene into the
pGEX-5T vector. The thrombin cleavage site (PRGS) was
replaced with a sequence recognized by SplD (PRWLL↓TSLG;
underlined) by site-directed mutagenesis. Protein expression
was carried out as described for the GST-SplD fusion protein.
The protein was purified to homogeneity by single-step affinity
chromatography on Glutathione Sepharose (Amersham
Biosciences). GST-RWLLTS-CRP was incubated with SplD in
50 mM Tris-HCl pH 8.0 at a molar ratio of 125:1 for 6 h at 37 °C
to achieve >95% hydrolysis. The cleavage site was determined
by N-terminal Edman degradation sequencing of the reaction
products.
Activity assays and initial substrate specificity
assessment
The proteolytic activity of SplD and its mutants was detected
by zymography [25] using β-casein as a substrate. In brief, the
samples were mixed with Laemmli sample buffer without a
reducing agent, incubated at room temperature for 15 min, and
then separated on a 12% (w/v) polyacrylamide gel containing
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0.1% β-casein. After PAGE, the SDS was removed by
incubating the gels for 30 min in 2.5% (v/v) Triton X-100. The
gels were developed overnight in 100 mM Tris-HCl, pH 7.5 at
37 °C, and stained with 0.1% (v/v) amido-black in 10% (v/v)
acetic acid. The zones of hydrolysis were visualized by de-
staining the gels in 1% (v/v) acetic acid. The optimum pH and
temperature of SplD were determined using soluble β-casein.
The extent of cleavage of the reporter protein was monitored
by SDS-PAGE.
Hydrolysis of native proteins was evaluated by incubation
with SplD at a 1:1 molar ratio for 24 h in 100 mM Tris-HCl, pH
8.0, at 37 °C and the reaction products were analyzed by SDS-
PAGE. The following proteins were tested: chicken egg white
lysozyme, ovalbumin, soyabean trypsin inhibitor, goat
immunoglobulins (IgGs), bovine serum albumin (BSA), GST, β-
casein, cytochrome c, carbonic anhydrase, human lactoferrin,
human serum transferrin, and human fibrinogen. Hydrolysis of
synthetic chromogenic and fluorogenic substrates (Table S1 in
File S1) was evaluated in the same conditions as for the native
proteins.
Edman degradation and matrix-assisted laser
desorption/ionization–time of flight (MALDI–TOF) mass
spectrometry (MS)
The products of hydrolysis of native protein substrates by
SplD were analyzed by N-terminal Edman degradation
sequencing (BioCentrum) of peptides separated by SDS-PAGE
and immobilized on polyvinylidene fluoride membranes, or by
MALDI-TOF MS.
Positional scanning synthetic combinatorial library
(PS-SCL)
The P1 substrate preference of SplD was determined using a
combinatorial library of synthetic, aminomethylcoumarin
(AMC)-labeled peptide substrates, as previously described
[26]. In brief, 16 sub-libraries were constructed with a general
structure of Ac-P4-P3-P2-P1-AMC; each sub-library contained
a fixed natural amino acid (except Met, Cys, Gly, or Trp) at the
P1 position and an equimolar mixture of those amino acids at
further positions. All sub-libraries were tested at a substrate
concentration of 9 mM in 50 mM Tris-HCl, pH 8.0. The active
enzyme concentration was 1 μM. Enzymatic activity was
monitored as an increase in fluorescence emission at 455 nm
(380 nm excitation).
Libraries of synthetic tetrapeptide substrates (LSTS)
The LSTS are composed of fluorescence-quenched
substrates of a general structure ABZ-X4-X3-X2-X1-ANB-NH2
where 5-amino-2-nitrobenzoic acid (ANB) quenches the
fluorescence of aminobenzoic acid (ABZ). The library
preparation and one of the possible modes of selection using
the release of quenched fluorescence following peptidyl moiety
hydrolysis by the test protease were performed as previously
described [27,28,29]. In brief, each of 19 X4 fixed sub-libraries
(1 mg/ml; positions X3-X1 contained equimolar mixtures of
tested residues) was incubated with the enzyme (14.4 μM), and
the increase in fluorescence was monitored (excitation, 320
nm; emission, 410 nm). X4 was fixed, being the residue of the
most active sub-library, and 19 X3 fixed sub-libraries were
constructed; the selection was repeated to determine the most
preferred X3 residue. Further positions were deconvoluted in a
similar manner.
The second mode of selection involved monitoring of ANB-
NH2 release by recording the increase in absorbance. The
major difference between the two modes of selection is based
on the fact that, in the second mode, the X4–X1 positions of
the initial library correspond to positions P4–P1 of the
substrate, but in the first mode, each iteration may select
substrates hydrolyzed at several different sites (Note S1 in File
S1). ANB release-based selection was performed as follows:
19 sub-libraries were prepared, each containing 1 of the 19
natural amino acid residues (except Cys) at position P4, while
positions P3–P1 contained equimolar mixtures of these
residues. Each sub-library (3 mg/ml final concentration) was
incubated for 90 min with the enzyme (1.15 μM) and the
increase in absorbance was monitored at 410 nm. P4 was then
fixed with the residue corresponding to the most efficiently
hydrolyzed substrate. Then, 19 sub-libraries were synthesized,
in each of which the P3 position contained 1 of the 19 natural
amino acid residues and positions P2 and P1 contained
equimolar mixtures of these residues. The procedure was
iterated until all of the positions of the most efficiently
hydrolyzed substrate were determined.
The substrates that were most efficiently hydrolyzed in both
selection processes were resynthesized. The hydrolysis sites
were determined by high-performance liquid chromatography
(HPLC)-MS and the kinetics of hydrolysis were measured as
previously described [30,31].
Cellular library of peptide substrates (CLiPS)
The complete consensus sequence that was recognized and
cleaved by SplD was determined using a CLiPS methodology,
as previously described [32]. In brief, a library of 6 × 107 E. coli
clones, each displaying a surface bait composed of streptavidin
peptide ligand and a substrate sequence consisting of eight
consecutive, randomized amino acids and the SH3 domain
binding peptide, was screened for proper bait display and SplD
hydrolysis using fluorescence-activated cell sorting. First, the
clones exhibiting both red and green fluorescence after
incubation with phycoerythrin-conjugated streptavidin (50 nM)
and SH3 domain-conjugated green fluorescence protein (250
nM) were selected. The selected clones were incubated for 2.5
h with 5.5 μM SplD in 0.2 M Tris-HCl, pH 7.6. Clones
expressing substrates that were specifically hydrolyzed were
isolated by sorting red cells only. After several consecutive
rounds of sorting while gradually decreasing the incubation
time from 2.5 h to 40 min, the cleavage of individual clones was
analyzed by incubation with 5.5 μM SplD for 30 min. The
hydrolyzed clones were sequenced (Table 1; Table S2 in File
S1) and the data were analyzed to determine the consensus
sequence recognized by SplD.
Crystallization and structure determination
SplD was concentrated to 40 mg/ml by ultrafiltration in 5 mM
Tris-HCl, 50 mM NaCl, pH 8.0. Sitting drop vapor diffusion
screening was performed at room temperature (~20 °C). After
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several weeks, crystals appeared in the Index 39 (0.1 M
HEPES pH 7.0, 30% Jeffamine ED-2001) and Index 95 (0.1 M
KSCN, 30% Polyethylene glycol monomethyl ether 2,000)
solutions (Hampton Research). Further optimization yielded the
best crystals in 30%–32.5% Jeffamine ED-2001 in 0.1 M
HEPES, pH 6.5–7.5 and 30%–33% PEG 2000 monomethyl
ether containing 0.1–0.5 M KSCN. SplD crystals were
cryopreserved in 25% (v/v) glycerol in mother liquor and flash-
cooled in liquid nitrogen. The diffraction data were collected at
100 °K on a Rigaku MicroMax 007HF rotating anode
diffractometer. Data were indexed and integrated using
MOSFLM software [33]. Further computational steps were
performed using programs contained in the CCP4 software
package [34] . Data were scaled using SCALA [35,36].
Molecular replacement was performed using Phaser software
Table 1. Experimentally determined SplD cleavage sites
within proteins and peptides.
 P4 P3 P2 P1 P1'
Bovine β-casein L A L A R
 K Y P V E
 L T L T D
 P F A Q T
 P V V V P
GST A W P L Q
GST-WELQ-SplD P W E L Q
Synthetic substrate A A P L pNA
CLiPS T Y P I S
 V Y G I S
 L Y P I S
 R W L L S
 T H I L S
 R Y L L T
 Q W L L A
 Q Y L L G
 V Y S T S
 R Y W T S
 R Y P T S
 R W P T S
 R Y L T S
 R Y L T G
 R Y P T S
 L F P V S
 V Y P V D
 M W Q V S
Consensus sequence R Y/W P/L T/L/I/V S
Fusion protein (RWLLTS) R W L L T
Residues corresponding to the consensus sequence are highlighted bold.
Cleavage products of β-casein, GST, GST-Q-SplD and RWLLTS fusion protein
were identified by mass spectrometry and Edman degradation sequencing.
Prediction of cleavage sites within CLiPS determined sequences is based on
sequence alignment, PS-SCL and LSTS data and experimental analysis of
cleavage of a consensus sequence engineered into a fusion protein. In case of
CLIPS substrates only those corresponding to the consensus are depicted – for a
full list of substrates selected using CLIPS see Table S2 in File S1.
doi: 10.1371/journal.pone.0076812.t001
[37] with an alanine search model based on the structure of
SplA (Protein Data Bank [PDB] code 2W7S). The structures
were refined in multiple rounds of manual model building and
restrained refinement, which were performed using COOT [38]
and Refmac 5.0 [39] software, respectively. Throughout the
refinement, 5% of the reflections were used for cross-validation
analysis [40], and the behavior of Rfree was used to monitor the
refinement strategy. In the final steps of refinement, water
molecules were added using Arp/Warp [41] and were manually
inspected. The final models were deposited in PDB under
accession numbers 4INK and 4INL. Data collection and
refinement statistics are summarized in Table 2.
Modeling of substrate binding
Computer model of a short peptide (H-WLTS-OH) spanning
the consensus sequence recognized by SplD, was constructed
and optimized in the MMFF94 force field using Avogadro
software [42,43]. Substrate peptide was manually placed at the
active site cleft of SplD by analogy to canonical inhibitors
[44,45,46]. The resulting system was hydrated (~12,000 water
molecules) and charge neutralized. The system was
Table 2. Data collection and refinement statistics.
PDB ID 4INK 4INL
Data Collection   
Space group F432 F432
Cell constants (a=b=c) (Å) 175.56 174.27
Wavelength (Å) 1.542 1.542
B factor (Wilson) (Å2) 20.7 29.6
Resolution range (Å) 27.76 - 1.56 26.27- 2.10
Completeness (%) 98.2 (94.9) 86.7 (72.1)
Rmerge (%) 0.053 (0.255) 0.076 (0.159)
Rmeas (%) 0.057 (0.278) 0.089 (0.205)
Observed reflections 233543 (28416) 35580 (2464)
Unique reflections 32697 (4508) 11885 (1394)
I/σ(I) 15.6 (4.1) 11.0 (3.1)
Average multiplicity 7.1 (6.3) 3.0 (1.8)
Refinement   
Resolution (Å) 25.0 - 1.56 20.0 - 2.10
Number of reflections used 30930 11303
R-factor (%) 17.9 21.2
Rfree (%) 21.0 25.6
Average B (Å2) 20.38 31.36
RMS from ideal values   
Bond length (Å) 0.012 0.011
Bond angles (°) 1.467 1.529
Ramachandran statistics (%)   
Most favored regions 96.0 96.0
Additionally allowed regions 4.0 4.0
Generously allowed regions 0 0
Content of asymmetric unit   
Number of protein molecules/residues/atoms 1/203/1595 1/201/1510
Number of solvent molecules 329 66
Statistics for the highest shell are listed in parentheses.
doi: 10.1371/journal.pone.0076812.t002
SplD Protease of S. aureus
PLOS ONE | www.plosone.org 4 October 2013 | Volume 8 | Issue 10 | e76812
minimized, protein and substrate positions were constrained,
and two 100 ps equilibrating molecular dynamics (MD)
simulations were performed, with the first in the NVT ensemble,
and the second in the NpT ensemble. Constraints on the
protein and the substrate were removed and the molecular
dynamics of the system was simulated over 5 ns. CHARMM
2.7 parameters were used for the protein, substrate, and ions
[47,48], while transferable intermolecular potential 3 point
(TIP3P) parameters [49] were used for water. Long-range
electrostatic interactions were accounted for using the Particle
Mesh Ewald (PME) summation method [50]. Simulations were
carried out at a constant pressure (1 atm) controlled using the
Parrinello–Rahman method [51]. The temperature (310 K) was
controlled independently using a modified Berendsen
thermostat [52]. Periodic boundary conditions with minimum
image convention and a cutoff of 10 Å were used in all three
directions. The time step was set at 2 fs. The simulations and
data analyses were performed using GROMACS 4.5.3
software [53,54]. Hydrogen bonds were defined according to
the following criteria: a distance between a hydrogen bond
donor (d) and an acceptor (a) of ≤3.5 Å, and an angle between
the a–d vector and the d–H bond of ≤30 °.
Bioinformatic analysis
Human (Homo sapiens) and staphylococcal (S. aureus)
proteomes were analyzed for the presence of consensus
sequences recognized by SplD using BLAST searches of the
Uniprot database. Initial hits were manually verified in the
context of known niches of S. aureus commensal colonization
and pathological infection. The steric accessibility of the
potential cleavage sites was taken into account if information
was available.
Results
Production of recombinant SplD protease
The recombinant SplD protease was obtained by
heterologous expression in E. coli as a GST fusion protein.
Approximately 1 mg of purified protein was obtained per 1 L of
starting culture. The initial constructs were engineered to
remove the purification tag by using factor Xa or CleanCut
protease to generate recombinant SplD with the native N-
terminus (NH2-Glu(1)-Asn-Ser(3)-...). To achieve this, the
thrombin cleavage site in the pGEX-5T vector (LVPR↓GS-E(1))
was replaced with a factor Xa site (IEGR↓-E(1)) or a CleanCut
site (LVPWELQ↓-E(1)) by site-directed mutagenesis. The
fusion protein with the factor Xa cleavage site was not
processed by factor Xa, even after prolonged incubation. By
contrast, the latter fusion protein was efficiently cleaved in the
presence of CleanCut protease, but N-terminal sequence
analysis of the final product revealed glutamine instead of the
expected glutamic acid at the N-terminus (Q-SplD). This
cleavage at the CleanCut site (LVPWEL↓Q-E(1)) was also
observed when incubated without the external protease, which
indicates autoproteolysis of the fusion protein by SplD itself.
Therefore, to exploit this autoprocessing to generate
recombinant SplD with a native N-terminus, the cleavage site
was modified to a LVPWEL-E(1) sequence. Unfortunately, this
fusion protein underwent slow autoproteolysis within the GST
moiety (AWPL↓Q), some distance from the expected cleavage
site.
Previous studies of SplB protease confirmed the importance
of appropriate N-terminal processing for enzymatic activity [21].
However, Q-SplD and GS-SplD, which were obtained by
autoprocessing or thrombin processing of the fusion proteins,
were active in the zymography assay with β-casein as a
substrate, and were considered suitable for further
characterization (see Discussion). Therefore, all further
analyses were performed using GS-SplD (and its mutants), a
recombinant SplD protease containing the Gly-Ser dipeptide at
the N-terminus, as compared with mature SplD obtained from
staphylococci.
Initial characterization of SplD proteolytic activity
Once the activity of recombinant SplD had been confirmed
by zymography, the cleavage of multiple different native
proteins and synthetic substrates was analyzed to determine
the substrate specificity of the protease. The optimum pH and
temperature of SplD were determined using β-casein as the
substrate (pH 8.0; 37 °C). Analysis of the effects of SplD on
native proteins revealed appreciable activity against β-casein
and GST, but not other proteins, despite testing excess
enzyme concentrations and prolonged incubation times. The
cleavage products were identified by MS and N-terminal
sequence analysis. The identified cleavage sites are
summarized in Table 1. SplD did not cleave several proteins,
including chicken egg white lysozyme and ovalbumin, soybean
trypsin inhibitor, goat IgG fraction, BSA, cytochrome c, carbonic
anhydrase, human lactoferrin, human serum transferrin, and
human fibrinogen.
Hydrolysis of a number of synthetic substrates was also
evaluated. Because the S1 family proteases are specific for P1
substrate residues [55], the tested compounds included
substrates with P1 residues corresponding to the SplD
cleavage sites in GST and β-casein. In addition, we also
examined the hydrolysis of other commercially available
substrates to extend the repertoire of tested sequences. Of 33
compounds tested (Table S1 in File S1), we only detected the
hydrolysis of Suc-Ala-Ala-Pro-Leu-pNa. However, because the
reaction was inefficient, kinetic studies and use of the substrate
for routine detection of activity were considered unfeasible.
Although multiple substrates were tested under favorable
conditions, very few were actually hydrolyzed. Therefore, these
initial studies prompted our preliminary conclusion that the
substrate specificity of the SplD protease is limited and is
probably determined at the S1 and other subsites.
Determination of SplD substrate preference at
nonprimed positions using combinatorial libraries of
synthetic peptide substrates
To comprehensively determine the preference of SplD for
residues at the P4-P1 substrate positions, the protease was
probed with LSTS, with a general structure of ABZ-P4-P3-P2-
P1-ANB-NH2. The libraries were deconvoluted, starting from
P4, by monitoring the absorbance of the released ANB, until
SplD Protease of S. aureus
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SplD preference for all tested substrate positions was
determined.
SplD selected amino acids with a small, hydroxyl group
containing side chains (threonine and serine) and aliphatic side
chains (alanine, isoleucine, and valine) at position P1 (Figure
1), with threonine being the preferred residue. These results
confirm and substantiate the data obtained by analyzing the
cleavage sites in native proteins, as described above (Table 1).
At the other subsites, leucine was preferred at P2, but other
aliphatic side chains and proline were also accepted. Unusually
for the S1 family of proteases, SplD showed very limited
substrate preference at P3, where the aromatic side chains of
tyrosine, phenylalanine, and tryptophan were almost
exclusively selected. Residues of different physicochemical
properties were selected at the P4 subsite, including positively
charged (arginine and lysine), aliphatic (alanine, isoleucine,
and leucine), and aromatic (tyrosine) residues or proline, but
arginine-containing substrates were hydrolyzed most efficiently.
The P1 substrate residue is the primary determinant of
specificity for the S1 family of proteases. To evaluate whether
the direction of substrate deconvolution or the identity of the
reporter group affected the result of the LSTS screening, we
reevaluated SplD preference at P1 using a different
experimental approach, the PS-SCL. Sixteen sub-libraries with
a general structure of acetyl-P4-P3-P2-P1-AMC, with a fixed
residue at P1 position and an equimolar mixture of the tested
residues at positions P2–P4, were incubated with the protease
Figure 1.  Substrate specificity of SplD at P4-P1 subsites.  Substrate preference of SplD protease was determined using
libraries of synthetic tetrapeptide substrates (LSTS). Libraries of a general structure ABZ-P4-P3-P2-P1-ANB-NH2 were
deconvoluted starting form P4 position as described in Materials and Methods. Vertical bars indicate the activity of the enzyme
(absorbance of released ANB-NH2) against particular sub-libraries normalized to the most active sub-library in each library.
Residues fixed at particular subsites (designated at the top of each panel) are indicated with the single-letter amino acid code. X
indicates randomized substrate position.
doi: 10.1371/journal.pone.0076812.g001
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and hydrolysis of the P1-AMC bond was monitored as an
increase in AMC-specific fluorescence.
Despite the different direction of deconvolution, the results
obtained using the PS-SCL approach substantiated the results
obtained using LSTS. SplD tended to hydrolyze substrates
accommodating amino acids with a small, hydroxyl group
containing (threonine and serine) or aliphatic side chains in the
P1 position (Figure 2). Again, threonine was the preferred
residue. SplD failed to recognize substrates containing
residues with aromatic or charged side chains, or proline. The
only exception was glutamine, but the substrates containing
this residue at P1 position were inefficiently hydrolyzed.
Selection of an efficient fluorescence-quenched
synthetic substrate of SplD using the LSTS approach
Using libraries of the same general structure (ABZ-X4-X3-
X2-X1-ANB-NH2) but a different selection approach, we
identified a sensitive, synthetic substrate for SplD. The library
was deconvoluted starting from the P4 position by monitoring
the release of quenched fluorescence.
In the X4 fixed library, the sub-libraries containing alanine,
threonine, and serine were hydrolyzed most efficiently, while
those containing asparagine, glutamine, leucine, isoleucine,
and valine were also efficiently cleaved (Figure 3). In the Ala-
X3 fixed library, the sub-libraries containing serine, threonine,
tyrosine, and phenylalanine residues were preferentially
cleaved. In the Ala-Tyr-X2 fixed library, the sub-library
Figure 2.  Substrate specificity of the SplD protease at the P1 subsite.  Substrate preference of SplD at P1 subsite was
determined using a positional scanning synthetic combinatorial library (PS-SCL) of a general structure Ac-P4-P3-P2-P1-AMC as
described in Materials and Methods. Vertical bars indicate the activity of the enzyme against each tested sub-library (fluorescence
of released AMC) normalized to the most active sub-library. Residues fixed at P1 subsite are indicated with the single-letter amino
acid code. X indicates randomized substrate position.
doi: 10.1371/journal.pone.0076812.g002
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containing phenylalanine was preferred, but leucine, isoleucine,
histidine, and tryptophan were also accepted. Finally, SplD
strongly selected isoleucine, leucine, valine, and methionine in
the P3’ position (Ala-Tyr-Phe-X1 fixed library). In this selection
scheme, the X(n) positions of the library do not correspond to
the P(n) positions of the substrate, except for X1, which
corresponds to P3’. This is discussed in more detail in Note S1
in File S1.
The optimal substrates determined with the absorbance- and
fluorescence-based selection approaches were resynthesized
and the kinetics of their hydrolysis by SplD were determined
(Table 3). The cleavage sites were verified by HPLC-MS. ABZ-
Ala-↓-Tyr-Phe-Ile-ANB-NH2 was hydrolyzed more efficiently
than ABZ-Arg-Tyr-Leu-Thr-↓-ANB-NH2. We believe that the
lower rate of hydrolysis of ABZ-Arg-Tyr-Leu-Thr-ANB-NH2 is
due to the unnatural moiety in the P1’ position rather than the
preference of SplD to the peptidyl part of the tested substrates.
Comprehensive analysis of SplD substrate specificity
using CLiPS
Both PS-SCL and LSTS are composed of short, synthetic
peptides with bulky reporter groups. Moreover, both methods
rely on deconvolution to determine the protease preference at
subsequent positions of a substrate, and poorly reflect the
effects of subsite cooperativity on the rate of substrate
hydrolysis. To verify the substrate preference of SplD against
protein substrates, and to simultaneously account for subsite
cooperativity, we used a high-throughput CLiPS substrate
display and selection method [32]. The preferentially cleaved
substrates were selected from a pool of ~108 random
Figure 3.  Selection of an efficient fluorescence-quenched substrate of the SplD protease.  Synthetic tetrapeptide substrate
libraries of a general structure ABZ-X4-X3-X2-X1-ANB-NH2 were screened for efficient fluorescence-quenched substrates of SplD
as described in Materials and Methods. Vertical bars indicate the activity of the enzyme against a particular sub-library (released
fluorescence) normalized to the most active sub-library in each library. Residues fixed at particular subsites (indicated at the top of
each panel) are designated with the single-letter amino acid code. X indicates randomized substrate position.
doi: 10.1371/journal.pone.0076812.g003
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sequences displayed in the context of an E. coli surface
protein. Testing a large number of permutations within the eight
amino acid randomized sequence allowed us to determine the
substrate preference of the protease at the P(n) and P(n)’
subsites. The sequences that were most efficiently hydrolyzed
by SplD after multiple rounds of CLiPS selection are
summarized in Table 1 (Table S2 in File S1). Alignment of the
resulting sequences revealed a consensus of five consecutive
amino acid residues, R-(Y/W)-(P/L)-(T/L/I/V)-S, which was
recognized and efficiently cleaved by SplD.
The CLiPS method does not allow for direct determination of
the cleavage site within the consensus sequence. However,
comparison of the PS-SCL and LSTS profiles of SplD
specificity and the CLiPS consensus sequence clearly
indicates that the enzyme should specifically hydrolyze the
(T/L/I/V)-S peptide bond. To confirm this possibility, we
constructed a substrate composed of two globular partners
connected by a linker containing a variant of the consensus
sequence determined in CLiPS (RWLLTS). In the light of LSTS
profiling results, this variant has an ambiguous cleavage site,
either at the T-S peptide bond as suggested by P1 specificity or
at L-T peptide bond as suggested by P3 and P4 specificity. It
was purposely chosen to determine the influence of bulky and
charged residues that are likely to be selected at positions P3
and P4. SDS-PAGE confirmed that SplD cleaved this
engineered substrate into two peptides. N-terminal sequence
analysis of cleavage products revealed hydrolysis of the Leu–
Thr peptide bond within the consensus sequence, confirming
SplD specificity at P3 and P4 subsites. Therefore, the data
obtained using synthetic peptide substrate libraries was
confirmed by analyzing the specificity of SplD using protein
substrates. Thus, it is clear that SplD is a highly specific
staphylococcal extracellular protease that recognizes and
efficiently hydrolyzes substrates containing the consensus
sequence motif R-(Y/W)-(P/L)-(T/L/I/V)↓S.
Crystal structure of SplD
To explain the molecular basis of the limited substrate
specificity observed in biochemical assays, we crystallized and
solved the structure of SplD. Crystals were obtained under two
different crystallization conditions, and diffracted to resolutions
Table 3. Kinetics of hydrolysis of SplD substrates.
Substrate
Library (selection















CLIPS 14.7±2.7 1.5±0.1 102,772
ABZ-Trp-Leu-Val-↓-
Ser-ANB-NH2
CLIPS 31.1±5.1 1.9±0.2 59,768
*. for detailed description see Materials and Methods
doi: 10.1371/journal.pone.0076812.t003
of 1.56 Å and 2.10 Å. The data collection and the refinement
statistics are summarized in Table 2. Because both structures
belong to the same space group and are essentially identical
(RMSD of 0.24 Å for all Cα atoms) only the high-resolution
structure (PDB ID: 4INK) is discussed in this report. The lower
resolution structure (4INL) is provided for reference, and
confirms that the structural details are not dependent on the
crystallization conditions.
SplD has a chymotrypsin-like fold, typical of the S1 family of
proteases. The molecule consists of two β-barrel domains with
roughly perpendicular axes [56] (Figure S1 in File S1). The
active site is located in the interface between the domains.
Domain I is formed of residues Tyr15–Phe99 and the C-
terminal part of the protein (Ser190–Arg203). Domain II is
primarily composed of C-terminal residues (Pro114–Phe189)
and a small N-terminal fragment (Glu1-Ile7). An extended
segment encompassing residues Thr100–Glu113 links the two
domains. The entire molecule is well-defined by its electron
density, except for the side chain of the Glu1 and residues
Ser0 and Gly(-1) and the three solvent-exposed side chains of
lysine residues.
The high level of amino acid sequence homology with other
staphylococcal serine proteases is reflected by the structural
similarities. Superimposing the SplD structure with known
structures of other spl operon proteases yielded a RMSD of
0.93 Å (for 184 equivalent Cα atoms) for SplC, 1.08 Å (192) for
SplB, and 1.00 Å (184) for SplA. The structures of
epidermolytic toxins A and B, and V8 protease are also closely
related, with RMSD values of 1.77 Å (181), 1.91 Å (178), and
1.17 Å (170), respectively. Despite the low primary structure
identity, SplD can be superimposed on the type protease of the
S1 family (chymotrypsin) with a relatively low RMSD of 2.01 Å
(177).
Differences between the discussed structures are primarily
manifested in the arrangement of the surface loops, particularly
loops A (Trp20–Thr25) and D (Pro121–Gln129), and in a
region encompassing Val84–Thr100. Of particular significance
are the differences in loops C (Pro74–Asp78) and 3 (an α-turn
in SplD), which are determinants of substrate specificity
[45,57], and loop 1 (a γ-turn in SplD), a component of the S1
cavity.
Catalytic machinery
The most prominent features of the catalytic machinery of
the S1 family of serine proteases include a characteristic
spatial arrangement of side chains of the catalytic triad
residues (Asp102, His57, and Ser195; chymotrypsin
numbering) which provides the nucleophilic property of serine
Oγ [46], and an oxyanion hole, a charge-compensating
structure formed by the backbone amides of the catalytic triad
serine (n) and n-2 residues [58]. Both of these features are
present in the structure of SplD. The equivalent residues are
clearly defined by their electron densities. In the catalytic triad,
the side chain carboxyl oxygen of Asp78 forms a canonical,
short (2.53 Å) hydrogen bond with Nδ of His39. The side chain
of Ser156 is found in three alternative orientations (gauche+,
gauche- and trans; Note S2 in File S1; Figure S2 in File S1). In
the canonical gauche+ orientation, the Oγ of the catalytic triad
SplD Protease of S. aureus
PLOS ONE | www.plosone.org 9 October 2013 | Volume 8 | Issue 10 | e76812
serine forms a hydrogen bond with Nε of the catalytic triad
histidine. The catalytic triad residues of SplD can be
superimposed on the residues of V8 protease with an RMSD of
0.18Å (Figure 4). Overall, the catalytic triad of SplD assumes a
configuration that is typical of the active serine proteases of the
S1 family, demonstrating high conservation of this crucial
structure.
The structure of SplD reveals canonical arrangement of the
oxyanion hole formed by the backbone amide hydrogen atoms
within the Pro153–Gly154 and Ser155–Ser156 (catalytic triad
serine) peptide bonds. In SplD, Pro153 has main chain angles
Figure 4.  The crystal structure of SplD demonstrates canonical conformation of the catalytic triad and the oxyanion
hole.  (Upper panel) Catalytic triad residues and the main chain fragment constituting the oxyanion hole of SplD (limon) superposed
with corresponding residues of chymotrypsin (black). (Lower panel) Electron density (contoured at 1.1σ) around SplD fragment
depicted in the upper panel. Red sphere represents a water molecule. Dashed lines represent hydrogen bonds.
doi: 10.1371/journal.pone.0076812.g004
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of ϕ = -42 ° and ψ = 135 °, which correspond to those of the
equivalent Gly166 residue in V8 protease (PDB ID 1qy6; ϕ =
-50 ° and ψ = 130 °). Gly154 has main chain angles of ϕ = 153
° and ψ = -32 °, which are similar to those of the corresponding
Gly167 in V8 protease (ϕ = 150 ° and ψ = -29 °) (Figure 4;
Table S3 in File S1). This is important because the oxyanion
hole is not pre-formed in either SplB protease [22] or S1A
subfamily protease zymogens [59,60]. In the crystal structure, a
water molecule that accepts hydrogen bonds from both amide
hydrogen atoms occupies the oxyanion hole of SplD in the
absence of a substrate. Water coordination is found in the
structures of many members of the S1 family of proteases. It is
assumed that a substrate or a canonical inhibitor displaces the
water molecule during the initial stages of interaction with the
catalytic machinery.
The primary specificity pocket
Tight spatial fit and specific interactions of the P1 residue
side chain in the S1 pocket are the primary determinants of the
specificity of the chymotrypsin family of proteases. Accordingly,
the S1 specificity pocket of SplD is an easily distinguished
cavity that is adjacent to the catalytic triad Ser156 and the
oxyanion hole. The cavity is formed by loop 2 (Asp175–
Arg183), residues Ala149–Ser155 (including a γ-turn
corresponding to an extended loop 1 in chymotrypsin), and a
fragment of a β-sheet of one of the barrels (strands Met171–
Ser174 and Ser184–Phe185). The pocket is lined with the
backbone atoms of these residues, particularly 153–155 and
172–174, and the side chains of Val151, Ser155, Met171, and
Ser174. Although polar residues are involved in cavity
formation, only their Cβ atoms are exposed to the surface
resulting in a primarily hydrophobic pocket. Therefore, the
pocket is comparable to that of human neutrophil elastase
(HNE), which shows similar specificity to SplD (Figure S3 in
File S1).
Modeling of substrate binding
Having solved the atomic structure of SplD, we attempted to
define the mode of consensus substrate recognition using
molecular modeling. The extensive knowledge on substrate /
inhibitor binding in the S1 family of proteases [44,45,46] was
used to construct the initial model of SplD bound to a peptide
spanning residues P3-P1’ of the consensus substrate.
Molecular dynamics of the system was simulated over 5 ns and
the resulting trajectory was analyzed to in order to define the
interaction surface. The predicted interactions are summarized
in Figure 5 and Table S4 in File S1. The backbone atoms of the
substrate form canonical hydrogen bonds with the enzyme,
including two hydrogen bonds between P3 residue and Ser174
and a hydrogen bond between the P1 residue and Tyr172. The
side chain of the tryptophan residue at position P3 interacts
with Pro177 via van der Waals interactions. The P2 side chain
resides in a shallow pocket formed by the side chains of His39,
Asp78, and Tyr172. The P1 side chain resides in a canonical
S1 pocket. Apart from being stabilized by van der Waals
interactions the sidechain Oγ of a threonine residue at position
P1 forms a hydrogen bond with the sidechain of Ser156. The
backbone carbonyl oxygen of the P1 residue resides in the
oxyanion hole. The side chain of the P1’ residue alternately
forms transient hydrogen bonds with His39 or Ala23. Residues
further than P3 and P1’ were not included in the model
because of the speculative characteristics of the modeling
system in the lack of crystal structures documenting equivalent
interactions.
To evaluate the adequacy of our model we tested the
influence of residues having model predicted role in substrate
Figure 5.  Putative binding mode of the SplD consensus substrate.  (A) Residues P4 through P1’ of the consensus substrate
(blue) docked to SplD (surface model). (B) Schematic representation of interactions between the consensus substrate (thick lines)
and SplD (thin lines). Hydrogen bonds are shown as dotted lines.
doi: 10.1371/journal.pone.0076812.g005
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recognition on proteolytic activity and specificity of SplD
protease. Neither, the predicted S3 subsite distorting
Pro177Gly mutant, nor the predicted S2 subsite distorting
Tyr172Ala mutant demonstrated detectable activity against
ABZ-Trp-Leu-Thr-Ser-ANB-NH2, an efficient substrate of wild
type SplD protease (Table 3). At the same time, both mutants
retained proteolytic activity against β-casein. This
demonstrates that the mutations do not significantly affect the
overall protease structure, but have significant effect on
substrate recognition, consistent with the predictions of our
model. Furthermore, the model predicts an important role of a
hydrogen bond between the P1 threonine sidechain and
cataltyic triad serine in substrate recognition. This was tested
by comparing the kinetics of hydrolysis by wild type SplD of
CLIPS derived consensus sequence peptide substrate and an
identical substrate where threonine was substituted with valine
(Table 3). The affinity (Km) of the former substrate was
approximately two times stronger than that of the latter being in
line with the predictions of our model. Overall, we conclude that
the provided model sensibly predicts the interactions
responsible for substrate recognition by SplD protease.
Discussion
SplD activation
SplD shares 12% amino acid sequence identity with
chymotrypsin, the archetype protease of the S1 family [61].
Despite limited similarities in the primary structure, the tertiary
structure of the core of both proteins is almost identical, with an
RMSD of 2.01 Å over 177 equivalent Cα atoms. The majority of
proteases of the S1 family belong to subfamily S1A. The
activating role of N-terminal processing in this subfamily has
been extensively studied. In general, chymotrypsin-like
proteases are synthesized as inactive precursors containing N-
terminal extensions. Proteolytic processing of a zymogen
releases a new N-terminus, which forms a buried salt bridge
and induces structural rearrangement of the “activation
domain”. The rearrangement orders the S1 site and the
oxyanion hole creating an active protease [46]. This activation
mechanism is not conserved in the small subfamily S1B, which
contains all nine staphylococcal serine proteases and several
other enzymes. SplB and possibly SplA require accurate N-
terminal processing to achieve full activity, but the structural
details of activation differ from those found in the S1A
subfamily. Processing is also necessary for V8 protease, but
the activation mechanism differs from that of the S1A family
and SplB. Epidermolytic toxins possess an additional N-
terminal helix and are active without processing. Here, we
showed that SplD remains active, despite an artificial N-
terminal extension of one (Q-SplD) or two (GS-SplD) amino
acids, and the entire GST fusion tag. Despite testing multiple
approaches, including enterokinase and factor Xa processing
of GST fusion proteins, heterologous production and secretion
in a Gram-positive host, or purification from S. aureus, we were
unable to obtain SplD with an unmodified N-terminus.
Therefore, we were unable to compare the activities of
modified and native SplD. However, the following findings
suggest that exact N-terminal trimming is dispensable for the
activation of SplD. First, the kcat/KM value for the best identified
here SplD substrate (Table 3) was close to that reported for
best substrates of other serine proteases [46]. Second, unlike
other zymogens of the S1A subfamily, no deformation of the
active site was observed in the structure of GS-SplD.
In SplB, the N-terminal glutamic acid is positioned on the
surface of the protease by a network of hydrogen bonds.
Comparable interactions maintain the position of the N-terminal
Glu in the structure of SplA. In SplA and SplB, the hydrogen
bond network involves the side chain and the N-terminal amine
group of Glu1. Any modification at the N-terminus, including
elongation of the polypeptide chain, abolishes the ability of the
N-terminal amine group to form canonical hydrogen bonds and
therefore significantly reduces the activity of SplB (SplA has not
been tested in this context). Interestingly, we found no
differences in the activity of the SplD constructs evaluated in
this study, despite the presence of various modifications at the
N-terminus. In the structure of GS-SplD, Glu1 has a poorly
defined electron density and does not form any hydrogen
bonds. Further analyses revealed that this property is not
directly due to the artificial N-terminal extension. Instead, SplD
appears to have bypassed the requirement for precise N-
terminal trimming for its activation. When the N-terminus of
SplA or SplB is modeled on the structure of SplD, it becomes
clear that the conformation found in SplA and SplB is not
supported in SplD by interactions seen in SplA or SplB (Figure
S4 in File S1). In particular, the salt bridge between the side
chains of Arg112 in SplA (Arg115 in SplB) and Glu1 is not
retained in SplD because Pro114 is found at the position
equivalent to Arg112 in SplA (Arg115 in SplB). Second, the
interaction between loop 2 and the N-terminal amine
characteristic of SplA is not supported in SplD. In SplA, this
interaction is provided by a hydrogen bond with the side chain
of Glu179. In SplB, this region has a poorly defined electron
density, but it seems that loop 2 also transiently interacts with
the N-terminal amine. Loop 2 is well defined in SplD, but none
of the protruding side chains reaches the N-terminal amine,
even was it located in a similar position to that in SplA.
Although the N-terminal glutamic acid is conserved in all Spl
proteases, it seems that the activity of SplD is independent of
N-terminal trimming. We speculate that this independence is
associated with the natural change of Arg112 (Arg115) to
proline. In this context, it will be interesting to determine the
effects of N-terminus processing on the proteolytic activity of
SplE and SplF, which contain arginine and proline,
respectively, at the position equivalent to Arg115 of SplB.
The proteolytic activity of N-terminally extended SplD
explains the problems encountered trying to induce efficient
heterologous expression. Compared with the GST-SplA, GST-
SplB, and GST-SplC fusion proteins, which were efficiently
expressed in E. coli, GST-SplD required extensive
optimization, but the yields were still low, probably because of
a deleterious effect of overexpressing an active protease.
Primary specificity pocket
The catalysis mechanism and structural basis of substrate
recognition in the S1 family are among the most thoroughly
characterized aspects of enzymology. However, it is still
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difficult to predict the substrate specificity of a novel member of
the family using the amino acid sequence alone, which means
that experimental characterization is necessary. Here, we
showed that the activity of SplD is limited to substrates
containing alanine, valine, leucine, isoleucine, serine, and
threonine at position P1. Glutamine is also accepted, but such
substrates are cleaved with very low efficiency. Other residues
are excluded from the P1 site. Among chymotrypsin-like
proteases with known X-ray structures, one with a comparable
substrate specificity is HNE (Figure S3 in File S1) [62,63].
The S1 cavity of SplD and HNE is an interesting example of
convergent evolution that led to markedly different structural
organizations of the S1 pocket, but with comparable van der
Waals surfaces. The disposition of the main chain around the
cavity is almost identical in both structures, except for loop 2. In
HNE, the loop does not close the south-western part of the
pocket as closely as that observed in SplD. However, in HNE,
the resulting empty space is occupied by the side chain of
Phe192 and the molecular surfaces of both pockets are
comparable. Another significant difference is located at the
northern bottom part of the pocket. The bottom of this pocket is
lined with the side chain of Met171 in SplD and with the side
chain of Ala213 (equivalent to Met171 in SplD) and Phe228 in
HNE. Despite this difference, the van der Waals surface of this
section of the pocket is similar in both enzymes because the
positions of the side chain atoms of Met171 correspond to
pocket exposed atoms of Ala213 and Phe228. Further
differences were found in the southern and northern bottom
sides of the pocket that are lined respectively by the side
chains of Ser155 and Ser184 in SplD, and of Asp194 and
Asp226 in HNE. However, because only the Cβ atoms are
exposed to the surface of the pocket and the positions of these
atoms are equivalent in both structures, the shapes of the
pockets are similar. Therefore, despite the different
compositions of the residues that form the S1 pocket between
SplD and HNE, the overall physicochemical properties of the
cavity are similar, which explains the similar substrate
specificities of both enzymes.
Substrate recognition model
Having solved the crystal structure of SplD, we sought to
determine the likely binding mode of the consensus sequence
substrate. To achieve this, we performed homology modeling
and molecular dynamics analyses. Based on the extensive
characterization of the substrate/inhibitor–protease interaction
in the S1A family, the interactions at the S3-S1’ pockets were
likely to be modeled correctly. Modeling of the interactions
further than P3 and P1’ was not attempted because of limited
reference structural information. The validity of the proposed
model was verified using mutants of residues of predicted
importance in substrate recognition. These mutants
demonstrated no activity against specific substrate of wild type
SplD, but retained activity against nonspecific protein
suggesting a shift in substrate specificity of the mutants, in
favor of model predictions. Below, the feasibility of the
predicted model is further verified against the available
structural data. Interestingly, molecular modeling suggested
that the side chain of threonine at P1 is stabilized in the S1
binding pocket of SplD by an energetically favorable hydrogen
bond between threonine Oγ and the side chain hydroxyl of
catalytic triad Ser156, the central residue in the catalytic
process. PDB was queried to determine whether this
interaction was observed in previous crystallographic studies.
The structures of streptogrisin B in a complex with the Thr18
variant of the third domain of turkey ovomucoid inhibitor (PDB
ID 1CT2) [64] and an inhibitory complex between α-lytic
protease and its proregion (PDB ID 4PRO) [65], both contain a
hydrogen bond between Oγ of threonine at position P1 and the
side chain of catalytic triad serine, as observed in our model.
Unlike the S1 specificity pocket, the S2 and S3 subsites of
SplD do not form pronounced cavities. Leucine is often
selected at the S2 subsite by proteases of the chymotrypsin
family, resulting in a wealth of structural information. The
interactions formed at S2 subsite by the side chain of leucine at
position P2 are clearly defined in the complex between
chymotrypsin and N-Ac-Leu-Phe-CHO (PDB ID 1GGD),
between streptogrisin A and chymostatin (PDB ID 1SGC), and
in many other structures. In most of those enzymes, the P2
pocket is composed of a pronounced cavity formed by the side
chain of catalytic triad histidine, loop C, and loop 3 in some
enzymes. In SplD, loops C and 3 are short and are unable to
support classical S2 pocket formation. Instead, the P2 binding
site of SplD is a shallow patch formed by the side chains of
His39, Asp78, and Tyr172, rather than a cavity. Elements of
the S2 pocket provided by loop C in chymotrypsin are missing
in SplD. Nevertheless, despite the simpler pocket structure of
SplD, it is still able to support the limited specificity at the S2
subsite, as demonstrated by the results of our high-throughput
substrate screening studies.
The interaction between SplD and the backbone of the P3
substrate residue was modeled according to that of canonical
inhibitors. In this model, the two characteristic hydrogen bonds
(β-sheet-like bonds with Ser174) were preserved throughout
the simulation (Table S4 in File S1). Side chain interactions at
the S3 subsite are rarely defined in proteases from the
chymotrypsin family, and we are unaware of any structures that
could help to validate our predicted model. According to our
model, the substrate specificity at the S3 subsite is driven by a
“stacked-like” interaction between the P3 tryptophan indole
moiety and Pro177 and this prediction is favored by the
properties of Pro177Gly mutant. The contribution of such
bonds to binding energy was previously estimated to be ~7 kcal
mol-1 [66].
Potential physiological role of SplD
Although the role of spl operon proteases in staphylococcal
physiology remains unknown, some proteases may be involved
in the virulence of this bacterium. The current study did not
address this question, but provides important topics for further
investigation. Having determined the substrate preference of
SplD protease, we analyzed the human proteome for likely
targets. Of all of the putative SplD substrates identified (Table
S5 in File S1), several members of the olfactory receptor family
are particularly noteworthy. Olfactory receptors are expressed
in the nares, the primary colonization niche of S. aureus.
Because olfactory receptors are transmembrane proteins, their
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extracellular moieties may be directly accessible to the Spl
proteases. Moreover, putative cleavage sites in other members
of the olfactory receptor family were identified based on the
substrate specificities of SplA [23] and SplB [22]. Therefore, it
is tempting to speculate that the hydrolysis of olfactory
receptors by Spl proteases contributes to staphylococcal
persistence in the nares, although no experimental evidence is
currently available to support this hypothesis.
An important aspect of in silico substrate prediction is the
consistency between the physiological substrates and the
specificity determined in high-throughput assays.
Physiologically, the selection of substrates is determined by the
polypeptide sequence around the hydrolyzed peptide bond and
other factors. More abundant substrates may be kinetically
favored. Steric hindrance, compartmentalization, and the effect
of other factors should also be considered. Some proteases
with well-characterized physiological targets, in vitro, in high-
throughput screens, show preference for sequences that are
similar, although not identical to those recognized in the target
substrate [32] which complicates in silico prediction of targets.
However, it is certain that, in the S1 family, the S1 subsite
shows high specificity. In this context, the available data on the
substrate specificity of Spl proteases suggests that they exhibit
cooperative activity. SplA hydrolyzes substrates with tyrosine/
phenylalanine in the P1 position (chymotrypsin-like activity),
SplB cleaves substrates after glutamine, asparagine, or
aspartic acid (glutamyl endopeptidase-like activity), and SplD
selects threonine, isoleucine, leucine, valine, alanine, and
serine at P1 (elastase-like activity). Therefore, it will be
intriguing to determine whether the remaining three Spl
proteases exhibit activity that is complementary to SplA, SplB,
and SplD. The fact that all six spl genes are co-transcribed [18]
further strengthens the possibility of mutual activities.
Cooperation of proteases with complementary substrate
specificities has been extensively characterized for the
digestive enzymes trypsin, chymotrypsin, and pancreatic
elastase. Whether the Spl proteases play a specific role in
targeting a limited number of specific substrates, constitute a
general digestive system, or have another undocumented role,
remains to be determined in future studies.
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